Logo image of INVE

IDENTIV INC (INVE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:INVE - US45170X2053 - Common Stock

3.51 USD
+0.07 (+2.03%)
Last: 12/5/2025, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to INVE. INVE was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. INVE has a great financial health rating, but its profitability evaluates not so good. INVE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year INVE has reported negative net income.
In the past year INVE has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: INVE reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INVE reported negative operating cash flow in multiple years.
INVE Yearly Net Income VS EBIT VS OCF VS FCFINVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With an excellent Return On Assets value of 48.06%, INVE belongs to the best of the industry, outperforming 99.20% of the companies in the same industry.
With an excellent Return On Equity value of 50.51%, INVE belongs to the best of the industry, outperforming 99.20% of the companies in the same industry.
Industry RankSector Rank
ROA 48.06%
ROE 50.51%
ROIC N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
INVE Yearly ROA, ROE, ROICINVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

INVE has a Profit Margin of 314.18%. This is amongst the best in the industry. INVE outperforms 99.20% of its industry peers.
INVE's Profit Margin has improved in the last couple of years.
INVE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 314.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVE Yearly Profit, Operating, Gross MarginsINVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

8

2. Health

2.1 Basic Checks

INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INVE has more shares outstanding
Compared to 5 years ago, INVE has more shares outstanding
There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INVE Yearly Shares OutstandingINVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INVE Yearly Total Debt VS Total AssetsINVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 4.03 indicates that INVE is not in any danger for bankruptcy at the moment.
The Altman-Z score of INVE (4.03) is better than 62.40% of its industry peers.
There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.03
ROIC/WACCN/A
WACC8.89%
INVE Yearly LT Debt VS Equity VS FCFINVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

INVE has a Current Ratio of 21.70. This indicates that INVE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 21.70, INVE belongs to the best of the industry, outperforming 96.80% of the companies in the same industry.
A Quick Ratio of 20.77 indicates that INVE has no problem at all paying its short term obligations.
INVE's Quick ratio of 20.77 is amongst the best of the industry. INVE outperforms 97.60% of its industry peers.
Industry RankSector Rank
Current Ratio 21.7
Quick Ratio 20.77
INVE Yearly Current Assets VS Current LiabilitesINVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

INVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
INVE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 438.90% yearly.
INVE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.71%.
The Revenue for INVE have been decreasing by -20.49% on average. This is quite bad
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-38.71%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%

3.2 Future

Based on estimates for the next years, INVE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.33% on average per year.
Based on estimates for the next years, INVE will show a very strong growth in Revenue. The Revenue will grow by 30.86% on average per year.
EPS Next Y12.75%
EPS Next 2Y10.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-56.94%
Revenue Next 2Y-31.47%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
Also next year INVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVE Price Earnings VS Forward Price EarningsINVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVE Per share dataINVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INVE!.
Industry RankSector Rank
Dividend Yield N/A

IDENTIV INC

NASDAQ:INVE (12/5/2025, 8:00:02 PM)

3.51

+0.07 (+2.03%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners56.5%
Inst Owner Change-7.65%
Ins Owners3.57%
Ins Owner Change2.35%
Market Cap83.36M
Revenue(TTM)26.63M
Net Income(TTM)73.95M
Analysts82.22
Price Target5.44 (54.99%)
Short Float %0.76%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.44%
Min EPS beat(2)-3.34%
Max EPS beat(2)14.22%
EPS beat(4)2
Avg EPS beat(4)-2.42%
Min EPS beat(4)-58.98%
Max EPS beat(4)38.44%
EPS beat(8)2
Avg EPS beat(8)-46.26%
EPS beat(12)4
Avg EPS beat(12)-37.73%
EPS beat(16)7
Avg EPS beat(16)-47.74%
Revenue beat(2)1
Avg Revenue beat(2)0.62%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)4.36%
Revenue beat(4)3
Avg Revenue beat(4)4.05%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)7.63%
Revenue beat(8)3
Avg Revenue beat(8)-0.58%
Revenue beat(12)3
Avg Revenue beat(12)-2.25%
Revenue beat(16)4
Avg Revenue beat(16)-2.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.54
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS0.99
BVpS6.16
TBVpS6.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 48.06%
ROE 50.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 314.18%
GM N/A
FCFM N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.18%
Cap/Sales 7.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.7
Quick Ratio 20.77
Altman-Z 4.03
F-Score4
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)106.77%
Cap/Sales(3y)6.31%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y12.75%
EPS Next 2Y10.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.71%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%
Revenue Next Year-56.94%
Revenue Next 2Y-31.47%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%
EBIT growth 1Y-112.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.72%
EBIT Next 3Y45.38%
EBIT Next 5Y33.76%
FCF growth 1Y-45.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.95%
OCF growth 3YN/A
OCF growth 5YN/A

IDENTIV INC / INVE FAQ

Can you provide the ChartMill fundamental rating for IDENTIV INC?

ChartMill assigns a fundamental rating of 4 / 10 to INVE.


What is the valuation status for INVE stock?

ChartMill assigns a valuation rating of 0 / 10 to IDENTIV INC (INVE). This can be considered as Overvalued.


Can you provide the profitability details for IDENTIV INC?

IDENTIV INC (INVE) has a profitability rating of 3 / 10.


Can you provide the financial health for INVE stock?

The financial health rating of IDENTIV INC (INVE) is 8 / 10.